Eli Lilly is developing what could be the first oral GLP-1 agonist. Late-stage clinical trial data is coming this year. The stock has a steep valuation despite trading sideways since the summer ...

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical company’s weight-loss drug. Hours after Hims & Hers posted a blog ...

Eli Ellis's journey came full circle on Friday night, as he delivered a heart-stopping buzzer-beater to dethrone the back-to-back Overtime Elite champions, the City Reapers—the very team where ...

Aiming to create a "harmonic and sinuous" yet sturdy form for the bent bases, several woods were tested during the design process. "Every wood has its own characteristics, so we had to respect ...

As “The Bachelor” inches closer to a potential engagement, Grant Ellis said he was meticulous in his approach to fantasy suites. “I handle myself as if my wife would be watching this back ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will prevent heart attacks and strokes. By Gina Kolata As many as one in five ...

Eli Roth‘s The Horror Section has acquired “Jimmy and Stiggs,” marking the horror company’s first major deal since launching earlier this month, Variety can exclusively report. Directed ...

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).

As he adjusts the blinds in the study of his south London home, Elis James is in a good mood. "I feel fantastic," he says, as he tames the sunlight that had streamed in through the shutters ...

Get a high-probability setup with clear entry and exit points right here. Eli Lilly And Co LLY, on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small interfering ...